Juno Permanently Halts CAR T-Cell Study – Medscape
Medscape |
Juno Permanently Halts CAR T-Cell Study
Medscape The CAR T-cell approach, which involves taking T-cells from patients, engineering them, and then reinfusing them back into the patient, has produced dramatic results in clinical trials in leukemia and lymphoma patients. However, clinical trials with … Juno Halts Development of CAR T-Cell Cancer Immunotherapy Candidate JCAR015 Juno ditches lead CAR–T program following patient deaths After Trial Deaths, Juno Pivots and Scraps Lead CAR–T Therapy |
